| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |